Navigation Links
Global Intravenous Solutions (Parenteral Nutrition) Industry
Date:9/5/2013

NEW YORK, Sept. 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Intravenous Solutions (Parenteral Nutrition) Industry

http://www.reportlinker.com/p01609840/Global-Intravenous-Solutions-Parenteral-Nutrition-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

 

This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million.

 

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

 

The report profiles 30 companies including many key and niche players such as Actavis, Inc., B. Braun Melsungen AG, Baxter International, Inc., Claris Lifesciences Ltd., Fresenius SE & Co. KGaA, Fresenius Kabi AG, Sino-Swed Pharmaceutical Corp. Ltd., Hospira, Inc., Otsuka Pharmaceutical Factory, Inc., Marck Biosciences Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Terumo Corporation, The Galenica Group, and Vifor Pharma.

 

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

 

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

 

 

II. EXECUTIVE SUMMARY

 

1. INDUSTRY OVERVIEW II-1

Intravenous Solutions: A Key Aspect of the Parenteral

Nutrition Market II-1

Healthcare Economics amidst the Economic Crisis II-2

The Road Ahead II-3

Table 1: World Intravenous Solutions (Parenteral Nutrition

Market): Market Share Breakdown of Different Regional Markets

(includes corresponding Graph/Chart) II-3

 

Table 2: World Intravenous Solutions (Parenteral Nutrition

Market): Growth Potential Across Different Regional Markets

(includes corresponding Graph/Chart) II-4

Noteworthy Market Trends, Drivers, and Issues II-4

Non-volitional Nutritional Support Therapy - Vital for

Combating Malnutrition during Hospitalization II-4

Table 3: Daily Requirements for Adults (Male and Female) by

Nutrient Type II-5

 

Table 4: Energy Requirements by Age and Gender (includes

corresponding Graph/Chart) II-5

 

Table 5: Protein and Vitamin Requirements by Gender II-6

 

Table 6: Mineral Requirements by Gender and Mineral Type II-6

Rapidly Ageing Demographics to Propel Demand for Intravenous

Solutions (Parenteral Nutrition) II-6

Opportunity Indicator II-7

Table 7: Elderly Population (65+ Years) as a Percentage of

the Total Population: 2000 & 2025 (includes corresponding

Graph/Chart) II-7

 

Table 8: Global Population Statistics for the 65+ Age

Group: 2012 II-8

Intravenous Therapy in Outpatient Settings to Boost Market

Growth II-8

Growing Demand for Home Intravenous Therapies II-9

Rising Incidence of Chronic Diseases to Propel Growth of IV

Solutions Market II-9

Cancer Incidence Statistics II-10

Table 9: New Cancer Cases in the World by Affected Site:

2012 (in Thousands) (includes corresponding Graph/Chart) II-11

 

Table 10: Global Cancer Incidence by Income Group: 2012 (in

Thousands) (includes corresponding Graph/Chart) II-11

 

Table 11: Cancer Incidence in High Income Countries by

Site: 2012 (in Thousands) (includes corresponding

Graph/Chart) II-12

 

Table 12: Cancer Incidence in Upper Middle Income Countries

by Site: 2012 (in Thousands) (includes corresponding

Graph/Chart) II-13

 

Table 13: Cancer Incidence in Lower Middle Income Countries

by Site: 2012 (in Thousands) (includes corresponding

Graph/Chart) II-14

 

Table 14: Cancer Incidence in Low Income Countries by Site:

2012 (in Thousands) (includes corresponding Graph/Chart) II-15

Diabetes Mellitus Incidence Statistics II-15

Parental Nutrition Therapy Indicated for Diabetes Patients

with Non-functional Gastrointestinal Tract II-16

Table 15: Worldwide Prevalence of Diabetes Mellitus by

Region: 2012 & 2030 (includes corresponding Graph/Chart) II-17

Table 16: Prevalence of Diabetes Mellitus in Europe (2012 &

2030): Breakdown by Country and Age Group (In 000 People & %) II-18

 

Table 17: Prevalence of Diabetes Mellitus in South East

Asia (2012 & 2030): Breakdown by Country and Age Group (In

000 People & %) (includes corresponding Graph/Chart) II-19

 

Table 18: Prevalence of Diabetes Mellitus in Western Asia,

Pacific Regions (2012 & 2030): Breakdown by Country and

Age Group (In 000 People & %) II-20

 

Table 19: Prevalence of Diabetes Mellitus in South &

Central America (2012 & 2030): Breakdown by Country and

Age Group (In 000 People & %) II-21

 

Table 20: Prevalence of Diabetes Mellitus in Africa (2012 &

2030): Breakdown by Country and Age Group (In 000 People & %) II-22

 

Table 21: Prevalence of Diabetes Mellitus in Middle East &

North Africa (2012 & 2030): Breakdown by Country and Age

Group (In 000 People & %) II-23

Global HIV Statistics II-24

Table 22: Global Summary of the AIDS Epidemic in 2011 II-24

 

Table 23: Global HIV Statistics for the Year 2010 II-24

Parenteral Nutrition in Select Gastrointestinal Disorders II-24

Intravenous Infusion Technology to Influence the Future

Growth Prospects II-25

Pre-mixed IV Solutions: A Step towards Safer Medication

Practices II-25

The Need for Low-Cost Solutions II-26

Continuous Supply of Raw Material: Crucial for Production of

IV Solutions II-26

Rising Popularity of Intravenous Vitamin C for Cancer Treatment II-26

Increasing Demand for Peripheral Intravenous Nutrition II-27

Iron Replacement Therapies: An Opportunity Area for

Intravenous Solutions (Parenteral Nutrition) II-27

Issues II-27

Rising Preference for Enteral Nutrition: A Threat to

Parenteral Nutrition Market II-27

Cost Containment Continues to Pressurize Product Pricing II-28

Infection Control: A Prime Concern in IV Therapy II-29

Complacency of Hospitals & Worker/Patient Safety: A Key Issue II-29

Competition In the Parenteral Nutrition Market II-30

Table 24: Leading Players in the Global Parenteral Nutrition

Market (2012): Percentage Share Breakdown of Value Sales for

Baxter, Fresenius Kabi, B. Braun Melsungen, Hospira and

Others (includes corresponding Graph/Chart) II-30

 

2. INTRAVENOUS SOLUTIONS II-32

Intravenous Therapy II-32

Defining Intravenous Solutions II-32

Tonicity and Osmolality II-33

Production of IV Solutions II-33

Types of IV Solutions II-33

Colloid Solutions II-33

Crystalloid Solutions II-33

Properties of IV Solution Type Based on Concentration II-34

Isotonic Crystalloids II-34

Hypertonic Crystalloids II-35

Hypotonic Crystalloids II-35

Commonly Used Crystalloid Solutions II-35

Saline Solution II-35

Normal Saline II-36

Half-Normal Saline II-36

Quarter-Normal Saline II-36

Hypertonic Saline II-36

Dextrose II-36

Saline with Additional Ingredients II-36

Intravenous Sugar Solution II-36

Dextrose Solutions or D5W II-37

Other Types II-37

Pre-mixed IV Solutions II-37

Large and Small Volume Intravenous Solutions II-37

Devices Used in IV Solutions Administration II-38

Types of Intravenous Access Devices II-38

Peripheral Cannula II-38

Central IV Lines II-39

Implantable Ports II-39

Tunneled Lines II-39

Peripherally Inserted Central Catheter (PICC) II-39

IV Fluid Packaging II-40

Possible Risks in Intravenous Therapy II-40

Embolism II-40

Electrolyte Imbalance II-40

Extravasation/Infiltration II-40

Phlebitis II-41

Infection II-41

 

3. PARENTERAL NUTRITION - AN OVERVIEW II-42

An Introduction II-42

Parenteral Nutrition II-43

Sources of Parenteral Solutions II-44

Routes of Administration II-44

Types of Parenteral Nutrition Solutions II-45

Total Parenteral Nutrition (TPN) II-45

Daily Requirements for Total Parenteral Nutrition (TPN) in

Adults II-45

Daily Recommended Parenteral Nutritional Intakes for Newborns II-46

Partial Parenteral Nutrition (PPN) II-47

Home Parenteral Nutrition II-47

Parenteral Nutrition Formulations II-47

Standard Solutions II-47

Non-Standard Solutions II-48

Classification of Parenteral Nutrition by Type of Nutrients II-48

Amino Acids II-48

Carbohydrates II-48

Lipids II-49

Minerals & Electrolytes II-49

Micronutrients II-50

Vitamins II-50

Trace Elements II-51

Large and Small Volume Parenteral Solutions II-51

Large Volume Parenteral (LVP) Solutions II-51

Small Volume Parenteral (SVP) Solutions II-52

IV Fat Emulsions - Enabling Maintenance of Bodyweight II-52

Regulatory Prerequisites II-52

 

4. PRODUCT LAUNCHES II-53

FDA Clears Fresenius Kabi for Emergency Import of

Injectionable TPN Drugs II-53

Marck Biosciences Receives MCC Approval for Pharma Products

(South Africa) II-53

EC Grants Clearance for Ferumoxytol IV Iron Therapy II-53

Claris Receives USFDA Approval for Marketing Products in the

US (US) II-53

Taiho to Roll Out Aloxi® 0.75mg I.V Infusion Bag II-54

Baxter International Launches OLIMEL Emulsion II-54

Baxter International Launches NUMETA in Europe II-54

B. Braun Rolls Out NuTRIflex® Omega II-54

Episys Launches New Version of Ultimate Parenteral Nutrition

Module II-55

 

5. RECENT INDUSTRY ACTIVITY II-56

Hospira Recalls IV Electrolyte Solution II-56

Becton, Dickinson and Company Takes over Cato Software Solutions II-56

Otsuka Pharmaceutical Factory Forms a JV with Claris

Lifesciences and Mitsui II-56

B. Braun Establishes Pharmaceutical Plant in Fogelsville, US II-56

Baxter International Completes Acquisition of SIGMA

International (US) II-57

Aperture Health Takes Over Triad Therapeutics (US) II-57

Children's Hospitals and Clinics of Minnesota Deploys Cerner

CareAwareiBusTM of CareFusion II-57

Baxter Initiates Class I Recall of Automix Compounder II-58

Tosho Acquires Minority Interest in Health Robotics (Italy) II-58

Baxter International Acquires Baxa II-59

Baxter Healthcare Acquires Prism Pharmaceuticals II-59

Galenica Takes Over ViforUriachPharma II-59

Fresenius Kabi Establishes Manufacturing Plant in Vietnam II-60

Grifols to Set Up Form-Fill-Seal Production Lines for

Parenteral Solutions II-60

IVAL Pharma to Establish Pharmaceutical Plant in Uzbekistan II-60

National Medical Solutions to Establish Medical Facility in

Abu Dhabi II-60

Baxter Healthcare Obtains USFDA Approval for AVIVA Intravenous

Solutions (US) II-61

FMC and ViforPharma Team Up to Form Vifor Fresenius II-61

Marck Biosciences Acquire Injectible Facility of Ravish Infusion II-62

Lijun Forms JV with TonghuaDongbao Pharmaceuticals II-62

ADIH and Bram S.p.A. Ink Agreement for Wellpharma's IV

Production Facility II-62

Hospira Signs Multi-product Agreements with MedAssets II-62

Hospira Enters into Agreements with Novation II-62

Mission Health System Commences Production of RIVA-produced IV

Solution II-63

Mission Health Systems Selects Automation Solution from IHS II-63

Applied Research Associates Bags Contract for Packaged

Intravenous Fluids II-63

Hospira Announces Migration to Non-DEHP Based IV

Administration Units II-63

 

6. FOCUS ON SELECT GLOBAL PLAYERS II-64

Actavis, Inc. (US) II-64

B. Braun Melsungen AG (Germany) II-64

Baxter International, Inc. (US) II-65

Claris Lifesciences Ltd. (India) II-66

Fresenius SE & Co. KGaA (Germany) II-66

Fresenius KABI AG (Germany) II-66

Sino-Swed Pharmaceutical Corp. Ltd. (China) II-67

Hospira, Inc. (US) II-67

Otsuka Pharmaceutical Factory, Inc. II-68

Marck Biosciences Ltd. (India) II-68

Sichuan Kelun Pharmaceutical Co., Ltd. (China) II-68

Terumo Corporation (Japan) II-69

The Galenica Group (Switzerland) II-69

Vifor Pharma (Switzerland) II-69

 

7. GLOBAL MARKET PERSPECTIVE II-71

Table 25: World Recent Past, Current and Future Analysis for

Intravenous Solutions (Parenteral Nutrition) by Geographic

Region - US, Canada, Japan, Europe, Asia-Pacific, Latin

America, and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for the Years 2010 through

2018 (includes corresponding Graph/Chart) II-71

 

Table 26: World Historic Review for Intravenous Solutions

(Parenteral Nutrition) by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific, Latin America, and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) II-72

 

Table 27: World 15-Year Perspective for Intravenous Solutions

(Parenteral Nutrition) by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific, Latin America, and Rest of World Markets for the

Years 2004, 2013 and 2018 (includes corresponding Graph/Chart) II-73

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Table 28: The US Population by Age Group and Gender (2011)

(includes corresponding Graph/Chart) III-1

Impact of Patient Protection and Affordable Care Act (2010)

on the IV Solutions Market III-2

Increasing Usage of Intravenous Iron in the US III-2

Cancer Trends in the US III-3

Table 29: New Cancer Cases in the US by Gender and Affected

Site: 2012 III-3

 

Table 30: New Cancer Cases in Males in US by Leading Site:

2012 (includes corresponding Graph/Chart) III-4

Prevalence of Diabetes Mellitus in North America III-4

Table 31: Prevalence of Diabetes Mellitus in North America:

2012 (includes corresponding Graph/Chart) III-5

 

Table 32: North America Incidence of Type 1 Diabetes in

Children: 2012 (includes corresponding Graph/Chart) III-5

Strategic Corporate Developments III-6

Focus on Select Major Players III-9

B.Market Analytics III-12

Table 33: The US Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-12

 

Table 34: The US Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-12

 

2. CANADA III-13

A.Market Analysis III-13

Cancer Statistics in Canada III-13

Table 35: New Cancer Cases in Canada by Gender and Affected

Site: 2012 (includes corresponding Graph/Chart) III-13

 

Table 36: New Cancer Cases in Canada by Province: 2012

(includes corresponding Graph/Chart) III-14

 

Table 37: New Cancer Cases in Canada by Age Group: 2012

(includes corresponding Graph/Chart) III-15

Diabetes Statistics in Canada III-15

Table 38: Prevalence of Diabetes Mellitus in Canada: 2012

(includes corresponding Graph/Chart) III-15

Product Launches III-16

B.Market Analytics III-17

Table 39: Canadian Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-17

 

Table 40: Canadian Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-18

 

3. JAPAN III-19

A.Market Analysis III-19

Table 41: Prevalence of Diabetes Mellitus in Japan: 2012 &

2030 (includes corresponding Graph/Chart) III-19

Strategic Corporate Developments III-19

Focus on Select Players III-20

B.Market Analytics III-21

Table 42: Japanese Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-21

 

Table 43: Japanese Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-22

 

4. EUROPE III-23

A.Market Analysis III-23

Debt Crisis in Europe Affects Healthcare Industry III-23

Healthcare System . in State of Transition? III-23

Age Statistics III-24

Table 44: Europe Population Age Structure as a Percentage

of Total Population for the Year 2011 III-24

Cancer Trends III-25

Table 45: Cancer Incidence in Europe by Site: 2012 (in

Thousands) (includes corresponding Graph/Chart) III-25

Prevalence of Diabetes Mellitus in Europe III-26

Table 46: Prevalence of Diabetes Mellitus in Europe (2012 &

2030): Breakdown by Country and Age Group (In 000 People & %) III-26

Strategic Corporate Initiatives III-27

B.Market Analytics III-29

Table 47: European Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) by

Geographic Region - France, Germany, Italy, UK, Spain,

Russia, and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-29

 

Table 48: European Historic Review for Intravenous Solutions

(Parenteral Nutrition) by Geographic Region - France,

Germany, Italy, UK, Spain, Russia, and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-30

 

Table 49: European 15-Year Perspective for Intravenous

Solutions (Parenteral Nutrition) by Geographic Region -

Percentage Breakdown of Value Sales for France, Germany,

Italy, UK, Spain, Russia, and Rest of Europe Markets for the

Years 2004, 2013 and 2018 (includes corresponding

Graph/Chart) III-31

 

4a. FRANCE III-32

Market Analysis III-32

Table 50: French Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-32

 

Table 51: French Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-33

 

4b. GERMANY III-34

A.Market Analysis III-34

Select Key Players III-34

B.Market Analytics III-36

Table 52: German Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-36

 

Table 53: German Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-37

 

4c. ITALY III-38

Market Analysis III-38

Table 54: Italian Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-38

 

Table 55: Italian Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-39

 

4d. THE UNITED KINGDOM III-40

Market Analysis III-40

Table 56: The UK Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-40

 

Table 57: The UK Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-41

 

4e. SPAIN III-42

A.Market Analysis III-42

Grifols International S.A. - A Key Player III-42

B.Market Analytics III-43

Table 58: Spanish Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-43

 

Table 59: Spanish Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-44

 

4f. RUSSIA III-45

Market Analysis III-45

Table 60: Russian Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-45

 

Table 61: Russian Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-46

 

4g. REST OF EUROPE III-47

A.Market Analysis III-47

Focus on Select Key Players III-47

B.Market Analytics III-48

Table 62: Rest of European Recent Past, Current and Future

Analysis for Intravenous Solutions (Parenteral Nutrition)

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-48

 

Table 63: Rest of European Historic Review for Intravenous

Solutions (Parenteral Nutrition) Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-49

 

5. ASIA-PACIFIC III-50

A.Market Analysis III-50

Cancer Trends in Asia-Pacific III-50

Table 64: Cancer Incidence in Asia-Oceania by Site: 2011

(in Thousands) (includes corresponding Graph/Chart) III-50

Diabetes Statistics III-51

Table 65: Prevalence of Diabetes Mellitus in South East

Asia (2012 & 2030): Breakdown by Country and Age Group (In

000 People & %) (includes corresponding Graph/Chart) III-51

 

Table 66: Prevalence of Diabetes Mellitus in Western Asia,

Pacific Regions (2012 & 2030): Breakdown by Country and Age

Group (In 000 People & %) III-52

 

Table 67: Incidence of Type 1 Diabetes in Children by

Select Countries in the Western Pacific: 2012 (includes

corresponding Graph/Chart) III-53

B.Market Analytics III-54

Table 68: Asia-Pacific Recent Past, Current and Future

Analysis for Intravenous Solutions (Parenteral Nutrition) by

Geographic Region - China, Australia, and Rest of

Asia-Pacific Markets Independently Analyzed with Annual

Sales Figures in US$ Million for the Years 2010 through 2018

(includes corresponding Graph/Chart) III-54

 

Table 69: Asia-Pacific Historic Review for Intravenous

Solutions (Parenteral Nutrition) by Geographic Region -

China, Australia, and Rest of Asia-Pacific Markets

Independently Analyzed with Annual Sales Figures in US$

Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-55

 

Table 70: Asia-Pacific 15-Year Perspective for Intravenous

Solutions (Parenteral Nutrition) by Geographic Region -

Percentage Breakdown of Value Sales for China, Australia,

and Rest of Asia-Pacific Markets for the Years 2004, 2013

and 2018 (includes corresponding Graph/Chart) III-56

 

5a. CHINA III-57

A.Market Analysis III-57

Table 71: Chinese Intravenous Solutions Products Packaging

(2012): Percentage Share Breakdown of Volume Sales for Glass

Bottles, and Plastic Bottles & Non-PVC Soft Bags (includes

corresponding Graph/Chart) III-57

Strategic Corporate Development III-57

Focus on Select Key Players III-58

B.Market Analytics III-59

Table 72: Chinese Recent Past, Current and Future Analysis

for Intravenous Solutions (Parenteral Nutrition) Analyzed

with Annual Sales Figures in US$ Million for the Years 2010

through 2018 (includes corresponding Graph/Chart) III-59

 

Table 73: Chinese Historic Review for Intravenous Solutions

(Parenteral Nutrition) Analyzed with Annual Sales Figures in

US$ Million for the Years 2004 through 2009 (includes

corresponding Graph/Chart) III-60

 

5b. AUSTRALIA III-61

Market Analysis III-61

Table 74: Australian Recent Past, Current and Future

Analysis for Intravenous Solutions (Parenteral Nutrition)

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-61

 

Table 75: Australian Historic Review for Intravenous

Solutions (Parenteral Nutrition) Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-62

 

5c. REST OF ASIA-PACIFIC III-63

A.Market Analysis III-63

An Overview of the IV Solutions Market in India III-63

Strategic Corporate Developments III-63

Focus on Select Key Players III-64

B.Market Analytics III-67

Table 76: Rest of Asia-Pacific Recent Past, Current and

Future Analysis for Intravenous Solutions (Parenteral

Nutrition) Analyzed with Annual Sales Figures in US$ Million

for the Years 2010 through 2018 (includes corresponding

Graph/Chart) III-67

 

Table 77: Rest of Asia-Pacific Historic Review for

Intravenous Solutions (Parenteral Nutrition) Analyzed with

Annual Sales Figures in US$ Million for the Years 2004

through 2009 (includes corresponding Graph/Chart) III-68

 

6. LATIN AMERICA III-69

Market Analysis III-69

Table 78: Latin American Recent Past, Current and Future

Analysis for Intravenous Solutions (Parenteral Nutrition)

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-69

 

Table 79: Latin American Historic Review for Intravenous

Solutions (Parenteral Nutrition) Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-70

 

7. REST OF WORLD III-71

A.Market Analysis III-71

The Middle East III-71

Uganda III-71

Prevalence Statistics of Diabetes Mellitus III-72

Table 80: Prevalence of Diabetes Mellitus in Africa (2012 &

2030): Breakdown by Country and Age Group (In 000 People & %) III-72

 

Table 81: Prevalence of Diabetes Mellitus in The Middle

East & North Africa (2012 & 2030): Breakdown by Country and

Age Group (In 000 People & %) III-73

Product Launch III-73

B.Market Analytics III-74

Table 82: Rest of World Recent Past, Current and Future

Analysis for Intravenous Solutions (Parenteral Nutrition)

Analyzed with Annual Sales Figures in US$ Million for the

Years 2010 through 2018 (includes corresponding Graph/Chart) III-74

 

Table 83: Rest of World Historic Review for Intravenous

Solutions (Parenteral Nutrition) Analyzed with Annual Sales

Figures in US$ Million for the Years 2004 through 2009

(includes corresponding Graph/Chart) III-75

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 30 (including Divisions/Subsidiaries - 36)

 

The United States (10)

Japan (4)

Europe (11)

- France (1)

- Germany (3)

- The United Kingdom (1)

- Italy (1)

- Spain (1)

- Rest of Europe (4)

Asia-Pacific (Excluding Japan) (10)

Africa (1)

 

 

 

To order this report: Global Intravenous Solutions (Parenteral Nutrition) Industry

http://www.reportlinker.com/p01609840/Global-Intravenous-Solutions-Parenteral-Nutrition-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
2. Lexicon To Present At The Morgan Stanley Global Healthcare Conference
3. Global Cardiac Medical Devices 2009-2015 - Updated Report
4. Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015
5. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
6. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
7. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
8. One-Year Data From Global Atrial Fibrillation (AF) Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
9. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
10. Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
11. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
Breaking Medicine News(10 mins):